Publications by authors named "Klaas Ehrig"

Claim this Profile
C
Colonization of xenograft tumors by oncolytic vaccinia virus (VACV) results in enhanced tumor killing due to the involvement of myeloid cells.
Mehmet Okyay Kilinc, Klaas Ehrig, Maysam Pessian, Boris R Minev, Aladar A Szalay

J Transl Med· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of fractionated irradiation with anti-VEGF expressing vaccinia virus therapy enhances tumor control by simultaneous radiosensitization of tumor associated endothelium.
Lisa Buckel, Sunil J Advani, Alexa Frentzen, Qian Zhang, Yong A Yu, Klaas Ehrig

Int J Cancer· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Growth inhibition of different human colorectal cancer xenografts after a single intravenous injection of oncolytic vaccinia virus GLV-1h68.
Klaas Ehrig, Mehmet O Kilinc, Nanhai G Chen, Jochen Stritzker, Lisa Buckel

J Transl Med· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical evaluation of oncolytic vaccinia virus for therapy of canine soft tissue sarcoma.
Ivaylo Gentschev, Marion Adelfinger, Rafael Josupeit, Stephan Rudolph, Klaas Ehrig

PLoS One· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Significant Growth Inhibition of Canine Mammary Carcinoma Xenografts following Treatment with Oncolytic Vaccinia Virus GLV-1h68.
Ivaylo Gentschev, Klaas Ehrig, Ulrike Donat, Michael Hess, Stephan Rudolph

J Oncol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis